These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3538550)

  • 41. Analysis of macrophage phenotype in rejected corneal allografts.
    Oh JY; Lee HJ; Ko AY; Ko JH; Kim MK; Wee WR
    Invest Ophthalmol Vis Sci; 2013 Nov; 54(12):7779-84. PubMed ID: 24159090
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immune mechanisms of corneal allograft rejection.
    Niederkorn JY
    Curr Eye Res; 2007 Dec; 32(12):1005-16. PubMed ID: 18085464
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [ABO blood group expression in corneal allograft failures].
    Ardjomand N; Komericki P; Klein A; Mattes D; El-Shabrawi Y; Radner H
    Ophthalmologe; 2005 Oct; 102(10):981-6. PubMed ID: 15812644
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cytokine mRNA expression during experimental corneal allograft rejection.
    Torres PF; De Vos AF; van der Gaag R; Martins B; Kijlstra A
    Exp Eye Res; 1996 Oct; 63(4):453-61. PubMed ID: 8944552
    [TBL] [Abstract][Full Text] [Related]  

  • 45. B7-H1-induced apoptosis as a mechanism of immune privilege of corneal allografts.
    Hori J; Wang M; Miyashita M; Tanemoto K; Takahashi H; Takemori T; Okumura K; Yagita H; Azuma M
    J Immunol; 2006 Nov; 177(9):5928-35. PubMed ID: 17056517
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The extent of immunological privilege of orthotopic corneal grafts in the inbred rat.
    Katami M; Madden PW; White DJ; Watson PG; Kamada N
    Transplantation; 1989 Sep; 48(3):371-6. PubMed ID: 2675395
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Suppression of corneal allograft rejection by cyclosporin A.
    Salisbury JD; Gebhardt BM
    Arch Ophthalmol; 1981 Sep; 99(9):1640-3. PubMed ID: 6169331
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cytokine expression during orthotopic corneal allograft rejection in mice.
    Sano Y; Osawa H; Sotozono C; Kinoshita S
    Invest Ophthalmol Vis Sci; 1998 Sep; 39(10):1953-7. PubMed ID: 9727419
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Anti-IL-17 therapy restricts and reverses late-term corneal allorejection.
    Yin XT; Zobell S; Jarosz JG; Stuart PM
    J Immunol; 2015 Apr; 194(8):4029-38. PubMed ID: 25754737
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of alloantibodies on corneal allograft survival.
    Hegde S; Mellon JK; Hargrave SL; Niederkorn JY
    Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):1012-8. PubMed ID: 11923241
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ocular resurfacing and alloepithelial rejection in a murine keratoepithelioplasty model.
    Yao YF; Inoue Y; Miyazaki D; Shimomura Y; Ohashi Y; Tano Y
    Invest Ophthalmol Vis Sci; 1995 Dec; 36(13):2623-33. PubMed ID: 7499085
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Safety and Efficacy of OXB-202, a Genetically Engineered Tissue Therapy for the Prevention of Rejection in High-Risk Corneal Transplant Patients.
    Fouladi N; Parker M; Kennedy V; Binley K; McCloskey L; Loader J; Kelleher M; Mitrophanous KA; Stout JT; Ellis S
    Hum Gene Ther; 2018 Jun; 29(6):687-698. PubMed ID: 29361840
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Matching for Human Leukocyte Antigens (HLA) in corneal transplantation - to do or not to do.
    van Essen TH; Roelen DL; Williams KA; Jager MJ
    Prog Retin Eye Res; 2015 May; 46():84-110. PubMed ID: 25601193
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Expression of vascular endothelial growth factor and its receptors in inflamed and vascularized human corneas.
    Philipp W; Speicher L; Humpel C
    Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2514-22. PubMed ID: 10937562
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Analysis of primed donor-specific T cells in recipient mice bearing orthotopic corneal allografts.
    Sano Y; Ksander BR; Streilein JW
    Transplantation; 2000 Nov; 70(9):1302-10. PubMed ID: 11087144
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Transplantation antigens and keratoplasty.
    Stark WJ
    Dev Ophthalmol; 1981; 5():33-40. PubMed ID: 6177566
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Specific immunosuppression of corneal allograft rejection by combination of anti-VLA-4 and anti-LFA-1 monoclonal antibodies in mice.
    Hori J; Isobe M; Yamagami S; Mizuochi T; Tsuru T
    Exp Eye Res; 1997 Jul; 65(1):89-98. PubMed ID: 9237869
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of CXCL-1/KC production in high risk vascularized corneal allografts on T cell recruitment and graft rejection.
    Amescua G; Collings F; Sidani A; Bonfield TL; Rodriguez JP; Galor A; Medina C; Yang X; Perez VL
    Transplantation; 2008 Feb; 85(4):615-25. PubMed ID: 18347542
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Blood flow in rabbit eyes after keratectomy and corneal transplantation.
    Basu PK; Ohashi K; Hay JB
    Can J Ophthalmol; 1978 Apr; 13(2):89-92. PubMed ID: 25702
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Leukocytes in the graft bed associated with corneal graft failure. Analysis by immunohistology and actuarial graft survival.
    Williams KA; White MA; Ash JK; Coster DJ
    Ophthalmology; 1989 Jan; 96(1):38-44. PubMed ID: 2465520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.